Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells-Reference-Cited by-同舟云学术

Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells

Published:2019-07-09 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wei Di,Zhang Geng,Zhu Zheng,Zheng Yu,Yan Fei,Pan Chongxian,Wang Zhiyong,Li Xian,Wang Fuli,Meng Ping,Zheng Wanxiang,Yan Zhao,Zhai Dongsheng,Lu Zifan,Yuan Jianlin

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Allicin: chemistry and biological properties;Borlinghaus;Molecules,2014

2. Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells;Chen;BMC Pharmacol. Toxicol.,2014

3. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway;Chen;Int. J. Oncol.,2015

4. Obesity, hypertension, and the risk of kidney cancer in men;Chow;N. Engl. J. Med.,2000

5. Therapeutic potential of hesperidin and its aglycone hesperetin: cell cycle regulation and apoptosis induction in cancer models;Ferreira de Oliveira;Phytomedicine,2019

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemistry, pharmacological properties and pharmacokinetics of Citri Reticulatae Pericarpium: A systematic review;Journal of Ethnopharmacology;2024-10

2. Nobiletin alleviates macrophage M2 polarization by activating AMPK-mTOR-mediated autophagy in pulmonary fibrosis mice;International Immunopharmacology;2024-09

3. Protective and therapeutic effects of nobiletin against cisplatin-induced nephrotoxicity in rats;Biotechnic & Histochemistry;2024-08-02

4. Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties;Clinical and Experimental Health Sciences;2024-06-28

5. Nobiletin alleviates methotrexate-induced hepatorenal toxicity in rats;Biotechnic & Histochemistry;2024-04-02